Fusion Fund in connection with COSM Medical’s US$3.8 million seed round

On April 4, 2022, COSM Medical announced it had secured a US$3.8 million seed round led by Fusion Fund with participation from iGan Partners, MaRS IAF, Telus Pollinator Fund, and Archangel Fund. This seed round will enable COSM to further develop and launch its digital gynecology platform and gynecological prosthetics. The investment will also go toward expanding research and development, operations and plans to double its current team size.

Fusion Fund is a California-based venture capital firm.

COSM Medical is a Toronto-based start-up that combines novel physiological biomarkers, AI-driven cloud software, and 3D printing to create its custom prosthetics.

Osler, Hoskin & Harcourt LLP advised Fusion Fund with a team consisting of André Perey, Justin Dharamdial and Jordana Corber-Tovel (Emerging and High Growth Companies).